Scott Haden Kollins
Adjunct Professor in the Department of Psychiatry and Behavioral Sciences
Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals. Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA. He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.
Childress, Ann C., et al. “Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.” J Child Adolesc Psychopharmacol, vol. 27, no. 1, Feb. 2017, pp. 66–74. Pubmed, doi:10.1089/cap.2016.0002. Full Text
Schechter, Julia C., and Scott H. Kollins. “Prenatal Smoke Exposure and ADHD: Advancing the Field.” Pediatrics, vol. 139, no. 2, Feb. 2017. Pubmed, doi:10.1542/peds.2016-3481. Full Text
Lunsford-Avery, Jessica R., et al. “Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.” Clin Psychol Rev, vol. 50, Dec. 2016, pp. 159–74. Pubmed, doi:10.1016/j.cpr.2016.10.004. Full Text
Schoenfelder, Erin N., and Scott H. Kollins. “Topical Review: ADHD and Health-Risk Behaviors: Toward Prevention and Health Promotion.” J Pediatr Psychol, vol. 41, no. 7, Aug. 2016, pp. 735–40. Pubmed, doi:10.1093/jpepsy/jsv162. Full Text
Mitchell, John T., et al. “"I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD.” Plos One, vol. 11, no. 5, 2016, p. e0156614. Pubmed, doi:10.1371/journal.pone.0156614. Full Text Open Access Copy
Koblan, Kenneth S., et al. “Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.” Neuropsychopharmacology, vol. 40, no. 12, Nov. 2015, pp. 2745–52. Pubmed, doi:10.1038/npp.2015.124. Full Text
Vitiello, Benedetto, et al. “Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.” J Am Acad Child Adolesc Psychiatry, vol. 54, no. 7, July 2015, pp. 550–56. Pubmed, doi:10.1016/j.jaac.2015.04.004. Full Text
Childress, Ann C., et al. “The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.” J Child Adolesc Psychopharmacol, vol. 25, no. 5, June 2015, pp. 402–14. Pubmed, doi:10.1089/cap.2014.0176. Full Text
Mitchell, John T., et al. “Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.” Cogn Behav Pract, vol. 22, no. 2, May 2015, pp. 172–91. Pubmed, doi:10.1016/j.cbpra.2014.10.002. Full Text
Fuemmeler, Bernard F., et al. “PRE-PREGNANCY OBESITY AND OFFSPRING NEUROBEHAVIORAL DEVELOPMENT.” Annals of Behavioral Medicine, vol. 49, SPRINGER, Apr. 2015, pp. S252–S252.